Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Steroid Biochem Mol Biol ; 175: 125-135, 2018 01.
Artículo en Inglés | MEDLINE | ID: mdl-28216084

RESUMEN

Research carried out during the past two-decades extended the understanding of actions of vitamin D, from regulating calcium and phosphate absorption and bone metabolism to many pleiotropic actions in organs and tissues in the body. Most observational and ecological studies report association of higher serum 25-hydroxyvitamin D [25(OH)D] concentrations with improved outcomes for several chronic, communicable and non-communicable diseases. Consequently, numerous agencies and scientific organizations have developed recommendations for vitamin D supplementation and guidance on optimal serum 25(OH)D concentrations. The bone-centric guidelines recommend a target 25(OH)D concentration of 20ng/mL (50nmol/L), and age-dependent daily vitamin D doses of 400-800IU. The guidelines focused on pleiotropic effects of vitamin D recommend a target 25(OH)D concentration of 30ng/mL (75nmol/L), and age-, body weight-, disease-status, and ethnicity dependent vitamin D doses ranging between 400 and 2000IU/day. The wise and balanced choice of the recommendations to follow depends on one's individual health outcome concerns, age, body weight, latitude of residence, dietary and cultural habits, making the regional or nationwide guidelines more applicable in clinical practice. While natural sources of vitamin D can raise 25(OH)D concentrations, relative to dietary preferences and latitude of residence, in the context of general population, these sources are regarded ineffective to maintain the year-round 25(OH)D concentrations in the range of 30-50ng/mL (75-125nmol/L). Vitamin D self-administration related adverse effects, such as hypercalcemia and hypercalciuria are rare, and usually result from taking extremely high doses of vitamin D for a prolonged time.


Asunto(s)
Suplementos Dietéticos , Deficiencia de Vitamina D/dietoterapia , Vitamina D/análogos & derivados , Vitamina D/administración & dosificación , Adolescente , Adulto , Factores de Edad , Peso Corporal , Conducta Alimentaria , Femenino , Humanos , Hipercalcemia/sangre , Hipercalcemia/inducido químicamente , Hipercalcemia/patología , Hipercalciuria/sangre , Hipercalciuria/inducido químicamente , Hipercalciuria/patología , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Vitamina D/efectos adversos , Vitamina D/sangre , Deficiencia de Vitamina D/sangre
2.
Rev Endocr Metab Disord ; 18(3): 363-371, 2017 09.
Artículo en Inglés | MEDLINE | ID: mdl-28032296

RESUMEN

Perhaps the role of Vitamin D supplementation has been most exhaustively studied in calcium absorption, skeletal wellbeing, muscular potency, balance and risk of falling. Nonetheless, new data has emerged and the recent research on sarcopenia makes the topic increasingly interesting. Given the socioeconomic burden of the musculoskeletal consequences of hypovitaminosis D it is vital to keep abreast with the latest literature in the field. The recommended Vitamin D supplementation dose should suffice to increase the serum 25 hydroxyvitamin D level to 30 ng/mL (75 nmol/L) and this level should be optimally maintained with a maintenance dose, particularly for those diagnosed with osteoporosis.


Asunto(s)
Densidad Ósea/fisiología , Fenómenos Fisiológicos Musculoesqueléticos , Vitamina D/fisiología , Animales , Densidad Ósea/efectos de los fármacos , Calcio de la Dieta/farmacología , Suplementos Dietéticos , Salud , Humanos , Fenómenos Fisiológicos Musculoesqueléticos/efectos de los fármacos , Osteoporosis/dietoterapia , Osteoporosis/prevención & control , Vitamina D/farmacología , Deficiencia de Vitamina D/sangre , Deficiencia de Vitamina D/complicaciones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA